BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/29/2024 12:34:21 PM | Browse: 142 | Download: 545
Publication Name World Journal of Clinical Cases
Manuscript ID 91758
Country Ireland
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Prospective Study
Article Title Helicobacter pylori: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort
Manuscript Source Unsolicited Manuscript
All Author List Conor Costigan, Aoife M O'Sullivan, Jim O'Connell, Shreyashee Sengupta, Thomas Butler, Stephen Molloy, Fintan John O'Hara, Barbara Ryan, Niall Breslin, Sarah O'Donnell, Anthony O'Connor, Sinead Smith and Deirdre McNamara
ORCID
Author(s) ORCID Number
Conor Costigan http://orcid.org/0009-0000-8687-0776
Shreyashee Sengupta http://orcid.org/0000-0002-2306-7019
Barbara Ryan http://orcid.org/0000-0001-8400-9202
Sarah O'Donnell http://orcid.org/0000-0001-8209-8627
Anthony O'Connor http://orcid.org/0000-0003-1722-4820
Deirdre McNamara http://orcid.org/0000-0003-2324-3382
Funding Agency and Grant Number
Corresponding Author Conor Costigan, BM BCh, Assistant Professor, Doctor, Doctor, Lecturer, Trinity Academic Gastroenterology Group, School of Medicine-Trinity College Dublin, Centre for Learning and Development Tallaght University Hospital Dublin 24, Dublin D2, Ireland. conorcostigan92@gmail.com
Key Words Helicobacter pylori eradication; Helicobacter pylori; High dose amoxicillin; High dose amoxicillin dual therapy; Triple therapy
Core Tip We present a prospective assessment of high dose amoxicillin dual therapy (HDADT) for Helicobacter pylori in an Irish cohort. Ireland is a 'high dual-resistance country'-(clarithromycin and metronidazole)-mainstays of traditional treatment. Where bismuth-based therapy is unavailable, as in Ireland, European guidelines recommend HDADT can be considered. This is the first data on HDADT to date in Ireland, and despite promising data from Asia, European data remains scant. Our results show disappointing eradication rates; we discuss possible reasons why and provide clinical evidence to authorities for the need to make bismuth-therapy available in our country. We advise against HDADT in European populations.
Publish Date 2024-05-29 12:34
Citation

Costigan C, O'Sullivan AM, O'Connell J, Sengupta S, Butler T, Molloy S, O'Hara FJ, Ryan B, Breslin N, O'Donnell S, O'Connor A, Smith S, McNamara D. Helicobacter pylori: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort. World J Clin Cases 2024; 12(16): 2773-2779

URL https://www.wjgnet.com/2307-8960/full/v12/i16/2773.htm
DOI https://dx.doi.org/10.12998/wjcc.v12.i16.2773
Full Article (PDF) WJCC-12-2773-with-cover.pdf